Self-Funded cover image

Why Health Plans Pay $10,000+ For Drugs That Don't Even Work

Self-Funded

00:00

Alternatives: international sourcing, PAPs, biosimilars

Pramod critiques international sourcing and PAPs, and emphasizes buyers should focus on price and appropriate therapy.

Play episode from 01:00:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app